Continuous Glucose Monitoring Enables the Detection of Losses in Infusion Set Actuation (LISAs)

Reliable continuous glucose monitoring (CGM) enables a variety of advanced technology for the treatment of type 1 diabetes. In addition to artificial pancreas algorithms that use CGM to automate continuous subcutaneous insulin infusion (CSII), CGM can also inform fault detection algorithms that alert patients to problems in CGM or CSII. Losses in infusion set actuation (LISAs) can adversely affect clinical outcomes, resulting in hyperglycemia due to impaired insulin delivery. Prolonged hyperglycemia may lead to diabetic ketoacidosis—a serious metabolic complication in type 1 diabetes. Therefore, an algorithm for the detection of LISAs based on CGM and CSII signals was developed to improve patient safety. The LISA detection algorithm is trained retrospectively on data from 62 infusion set insertions from 20 patients. The algorithm collects glucose and insulin data, and computes relevant fault metrics over two different sliding windows; an alarm sounds when these fault metrics are exceeded. With the chosen algorithm parameters, the LISA detection strategy achieved a sensitivity of 71.8% and issued 0.28 false positives per day on the training data. Validation on two independent data sets confirmed that similar performance is seen on data that was not used for training. The developed algorithm is able to effectively alert patients to possible infusion set failures in open-loop scenarios, with limited evidence of its extension to closed-loop scenarios.

[1]  Josep Vehí,et al.  Robust Fault Detection System for Insulin Pump Therapy Using Continuous Glucose Monitoring , 2012, Journal of diabetes science and technology.

[2]  Giovanni Sparacino,et al.  Real-time detection of Glucose Sensor and Insulin Pump Faults in an Artificial Pancreas. , 2014 .

[3]  H. S. Wolff,et al.  iRun: Horizontal and Vertical Shape of a Region-Based Graph Compression , 2022, Sensors.

[4]  B. Wayne Bequette,et al.  Extended multiple model prediction with application to blood glucose regulation , 2012 .

[5]  B Wayne Bequette,et al.  A Novel Method to Detect Pressure-Induced Sensor Attenuations (PISA) in an Artificial Pancreas , 2014, Journal of diabetes science and technology.

[6]  A BuckinghamBruce,et al.  Inpatient Trial of an Artificial Pancreas Based on Multiple Model Probabilistic Predictive Control with Repeated Large Unannounced Meals , 2014 .

[7]  B. Wayne Bequette,et al.  Detecting sensor and insulin infusion set anomalies in an artificial pancreas , 2013, 2013 American Control Conference.

[8]  Marc D. Breton,et al.  1. Closed-Loop Control with DIAS vs. Sensor-Augmented Pump Therapy in Adolescents and Young Adults with Type 1 Diabetes at Camp (99-L) , 2015, Nederlands Tijdschrift voor Diabetologie.

[9]  Bruce A Buckingham,et al.  Randomized trial of infusion set function: steel versus teflon. , 2014, Diabetes technology & therapeutics.

[10]  Yi Zhang,et al.  A Hazard Analysis for a Generic Insulin Infusion Pump , 2010, Journal of diabetes science and technology.

[11]  O. Vega-Hernandez,et al.  Increasing security in an artificial pancreas: diagnosis of actuator faults , 2009, 2009 Pan American Health Care Exchanges.

[12]  Günter Niemeyer,et al.  A Closed-Loop Artificial Pancreas Based on Risk Management , 2011, Journal of diabetes science and technology.

[13]  B Wayne Bequette,et al.  Glucose Clamp Algorithms and Insulin Time-Action Profiles , 2009, Journal of diabetes science and technology.

[14]  Bruce Buckingham,et al.  Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes. , 2016, Diabetes technology & therapeutics.

[15]  A BuckinghamBruce,et al.  Randomized trial of infusion set function: steel versus teflon. , 2014 .

[16]  B. Wayne Bequette,et al.  Multivariate statistical analysis to detect insulin infusion set failure , 2011, Proceedings of the 2011 American Control Conference.

[17]  Christoph Ament,et al.  The Unscented Kalman Filter estimates the plasma insulin from glucose measurement , 2011, Biosyst..

[18]  Z. Benyo,et al.  LPV fault detection of glucose-insulin system , 2006, 2006 14th Mediterranean Conference on Control and Automation.

[19]  Anirban Roy,et al.  The effect of insulin feedback on closed loop glucose control. , 2011, The Journal of clinical endocrinology and metabolism.

[20]  I Guilhem,et al.  Technical risks with subcutaneous insulin infusion. , 2006, Diabetes & metabolism.

[21]  D.U. Campos-Delgado,et al.  Actuator fault tolerant control for an artificial pancreas , 2009, 2009 6th International Conference on Electrical Engineering, Computing Science and Automatic Control (CCE).

[22]  Eyal Dassau,et al.  Early Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes , 2016, Journal of diabetes science and technology.

[23]  Giovanni Sparacino,et al.  An Online Failure Detection Method of the Glucose Sensor-Insulin Pump System: Improved Overnight Safety of Type-1 Diabetic Subjects , 2013, IEEE Transactions on Biomedical Engineering.

[24]  Zhiwei Gao,et al.  From Model, Signal to Knowledge: A Data-Driven Perspective of Fault Detection and Diagnosis , 2013, IEEE Transactions on Industrial Informatics.

[25]  Eyal Dassau,et al.  Annals of the New York Academy of Sciences the Artificial Pancreas: Current Status and Future Prospects in the Management of Diabetes , 2022 .

[26]  B. Wayne Bequette,et al.  Challenges and recent progress in the development of a closed-loop artificial pancreas , 2012, Annu. Rev. Control..

[27]  B. Wayne Bequette,et al.  Mean Glucose Slope, Principal Component Analysis Classification to Detect Insulin Infusion Set Failure , 2011 .

[28]  Günter Niemeyer,et al.  Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals. , 2014, Diabetes technology & therapeutics.